Evidence map›Paper›PMID 17646391›Full record

ArticleMolecular and cellular biology2007

Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation.

Larbi Amazit, Luigi Pasini, Adam T Szafran, Valeria Berno, Ray-Chang Wu, Marylin Mielke, Elizabeth D Jones, Maureen G Mancini, Cruz A Hinojos, Bert W O'Malley and 1 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. The role of AIB1 in breast cancer.Oncology letters · 2012
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Larbi AmazitDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Luigi Pasini
Adam T Szafran
Valeria Berno
Ray-Chang Wu
Marylin Mielke
Elizabeth D Jones
Maureen G Mancini
Cruz A Hinojos
Bert W O'Malley
Michael A Mancini
Baylor College of Medicine · USInserm · FR

Funding

STEROID RECEPTOR FUNCTION AND NUCLEAR ORGANIZATIONR01DK055622 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI MANCINI, MICHAEL A · 1999 to 2007
$2.1M
NCI NIH HHS P01 CA06425NICHD NIH HHS HD08818NICHD NIH HHS U54 HD96008NIDDK NIH HHS DK55622NIDDK NIH HHS DK61589NIDDK NIH HHS R01 DK055622
6 · The paper itself

Abstract

The steroid receptor coactivator 3 gene (SRC-3) (AIB1/ACTR/pCIP/RAC3/TRAM1) is a p160 family transcription coactivator and a known oncogene. Despite its importance, the functional regulation of SRC-3 remains poorly understood within a cellular context. Using a novel combination of live-cell, high-throughput, and fluorescent microscopy, we report SRC-3 to be a nucleocytoplasmic shuttling protein whose intracellular mobility, solubility, and cellular localization are regulated by phosphorylation and estrogen receptor alpha (ERalpha) interactions. We show that both chemical inhibition and small interfering RNA reduction of the mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 (MEK1/2) pathway induce a cytoplasmic shift in SRC-3 localization, whereas stimulation by epidermal growth factor signaling enhances its nuclear localization by inducing phosphorylation at T24, S857, and S860, known participants in the phosphocode that regulates SRC-3 activity. Accordingly, the cytoplasmic localization of a nonphosphorylatable SRC-3 mutant further supported these results. In the presence of ERalpha, U0126 also dramatically reduces (i) ligand-dependent colocalization of SRC-3 and ERalpha, (ii) the formation of ER-SRC-3 complexes in cell lysates, and (iii) SRC-3 targeting to a visible, ERalpha-occupied and -regulated prolactin promoter array. Taken together, these results indicate that phosphorylation coordinates SRC-3 coactivator function by linking the probabilistic formation of transient nuclear receptor-coactivator complexes with its molecular dynamics and cellular compartmentalization. Technically and conceptually, these findings have a new and broad impact upon evaluating mechanisms of action of gene regulators at a cellular system level.

Indexed as

Active Transport, Cell NucleusAnimalsCell LineCell NucleusCytoplasmEndoplasmic ReticulumEpidermal Growth FactorExtracellular Signal-Regulated MAP KinasesHistone AcetyltransferasesHumansImmunohistochemistryNuclear ProteinsNuclear Receptor Coactivator 3PhosphorylationPromoter Regions, GeneticReceptors, EstrogenEpidermal Growth FactorExtracellular Signal-Regulated MAP KinasesHistone AcetyltransferasesNCOA3 protein, humanNuclear ProteinsNuclear Receptor Coactivator 3Receptors, EstrogenRecombinant Fusion ProteinsTrans-Activators

Identifiers

PMID17646391
PMCPMC2099228
OpenAlexW2166500786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.